Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility Chris SkedgelPatricia Cubi-MollaMireia Jofre-Bonet Current Opinion Open access 15 March 2023 Pages: 337 - 344
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Rachel HoutenNigel FleemanCarlo Palmieri Review Article Open access 21 April 2023 Pages: 345 - 358
Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review Tiziana MagniChiara RagniNatalia Meshchenkova Systematic Review Open access 11 March 2023 Pages: 359 - 371
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency Claudio JommiCarlotta Galeone Original Research Article Open access 10 February 2023 Pages: 373 - 381
Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067 Taihang ShaoMingye ZhaoWenxi Tang Original Research Article Open access 09 February 2023 Pages: 383 - 392
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States Aryana SepassiIla M. SaundersJonathan H. Watanabe Original Research Article Open access 25 February 2023 Pages: 393 - 404
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy Paolo Angelo CortesiCarla FornariLorenzo Giovanni Mantovani Original Research Article Open access 16 March 2023 Pages: 405 - 416
Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence Analysis John JacobChelsea StundenLuke Thomas Original Research Article Open access 11 April 2023 Pages: 417 - 429
Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain A. M. Alonso TorresA. G. Arévalo BernabéI. Oyagüez Original Research Article Open access 21 February 2023 Pages: 431 - 441
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland Amy DymondWill GreenGirish Gupta Original Research Article Open access 03 April 2023 Pages: 443 - 454
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer Andre VerhoekParneet CheemaDaniel Moldaver Original Research Article Open access 22 February 2023 Pages: 455 - 467
Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC) Owen Alan Edwards CooperOla GhatnekarJørn Skibsted Jakobsen Original Research Article Open access 03 February 2023 Pages: 469 - 477
Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands Rachel H. P. SchreursArina J. ten Cate-HoekManuela A. Joore Original Research Article Open access 19 April 2023 Pages: 479 - 491
Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial Charles YanJeff RoundMichael K. Stickland Original Research Article Open access 11 March 2023 Pages: 493 - 505